Allergan
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.
| Company type | Subsidiary of AbbVie Inc. |
|---|---|
| Industry | Pharmaceuticals |
| Predecessors | Allergan, Inc. and Actavis before the 2015 tax inversion and merger |
| Founded | May 16, 2013 upon the combination of Allergan Finance, LLC (Actavis) & Warner Chilcott March 17, 2015 renamed to Allergan Plc upon the merger of Allergan, Inc and Actavis |
| Headquarters | Clonshaugh Business & Technology Park, Coolock, D17 E400, , |
Number of locations | 40 manufacturing facilities, 27 global R&D centres and marketing/sales facilities worldwide. |
Area served | ~100 countries |
| Products | Branded pharmaceuticals |
| Revenue | $16.089 billion (2019) |
| -$5.142 billion (2018) | |
| Total assets | $94.699 billion (2019) |
| Total equity | $58.195 billion (2019) |
Number of employees | 17,800 (2018) |
| Parent | AbbVie Inc. |
| Website | www |
| Footnotes / references | |
Allergan plc was formed in March 2015 when Irish–registered Actavis plc acquired U.S.–registered Allergan, Inc., and assumed the Allergan name. In 2016, Allergan sold its generic drugs business, Actavis, to Teva Pharmaceuticals for $40.5 billion.
In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion. The merged company would be domiciled in the U.S. for tax purposes.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.